James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 110,000 shares at $5.64 ($647K) on 2018-06-08, disclosed to the SEC on 2018-06-14.
Open-market sale of $647k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.64 | 50,000 | $282K | 43.6% |
| 2 | $6.08 | 60,000 | $365K | 56.4% |
| Total | $5.88 avg | 110,000 | $647K | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |